Asgarova (42) found that when lung cancer cells undergo epithelial- mesenchymal transition (EMT) during treatment with TNF-α resulted in NF-κB recruitment at the promoter of PD-L1 and upregulation of PD-L1 expression. This evidence concerns the gene CD274 and lung carcinoma.